Hansa Biopharma in Search for New CFO Following Donato Spota’s Decision to Step Down
Hansa Biopharma AB has announced the resignation of Chief Financial Officer Donato Spota, effective February 28, 2024. The company has initiated the search for a successor to Spota, recognizing his pivotal role in guiding Hansa through a period of significant growth and transformation. Hansa is publicly listed on Nasdaq Stockholm...